A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

DOI Full Paper Access

169

Citations

24

References

2009

Year

Changhoon Yoo, Jenn-Jiang Hwang, Je Hyeong Kim, T W Kim, J S Lee, D H Park, S S Lee, Dong Wan Seo, S K Lee, MH Kim,

British Journal of Cancer

References

	Year	Citations

Page 1